This inventor holds 5 USPTO granted patents, plus 1 CIPO patent. Top assignee: Merck + Co., Inc.. Active years: 1979-1991.
Company Filing History:
Years Active: 1979-1991
Title: The Innovations of Robert E Dempski
Introduction
Robert E Dempski is a notable inventor based in Dresher, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of parkinsonism. With a total of 5 patents to his name, Dempski's work has had a profound impact on drug delivery systems.
Latest Patents
One of Dempski's latest patents is a controlled release combination of carbidopa and levodopa. This innovative matrix or monolithic drug delivery system allows for the controlled release of these two drugs, which are uniformly dispersed in a polymer vehicle. The concentration of the drugs is greater than their solubility in the polymer, providing a more effective treatment for parkinsonism. This formulation offers several advantages over the standard carbidopa/levodopa combinations currently in use.
Career Highlights
Dempski has built a successful career at Merck & Co., Inc., where he has been able to apply his expertise in drug formulation and delivery. His work has not only advanced the understanding of drug interactions but has also improved patient outcomes through innovative treatment options.
Collaborations
Throughout his career, Dempski has collaborated with esteemed colleagues, including Donald W Nibbelink and Scott A Reines. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Robert E Dempski's contributions to the field of pharmaceuticals, particularly through his patents on controlled release drug delivery systems, highlight his role as a leading inventor. His work continues to influence the treatment of parkinsonism and showcases the importance of innovation in medicine.